UA100672C2 - HUMANIZED ANTIBODY TO b-AMYLOID PROTEIN - Google Patents

HUMANIZED ANTIBODY TO b-AMYLOID PROTEIN

Info

Publication number
UA100672C2
UA100672C2 UAA200900880A UAA200900880A UA100672C2 UA 100672 C2 UA100672 C2 UA 100672C2 UA A200900880 A UAA200900880 A UA A200900880A UA A200900880 A UAA200900880 A UA A200900880A UA 100672 C2 UA100672 C2 UA 100672C2
Authority
UA
Ukraine
Prior art keywords
amyloidosis
amyloid
disease
diseases
dementia
Prior art date
Application number
UAA200900880A
Other languages
Russian (ru)
Inventor
Андреа ПФАЙФЕР
Мария ПИЛГРЕН
Андреас МУС
Райан Воттс
Original Assignee
Ас Иммуне Са
Дженентек, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ас Иммуне Са, Дженентек, Инк. filed Critical Ас Иммуне Са
Priority claimed from PCT/US2007/073504 external-priority patent/WO2008011348A2/en
Publication of UA100672C2 publication Critical patent/UA100672C2/en

Links

Abstract

The invention relates to a humanized antibody or a fragment thereof, which specifically binds to at least one epitope on the β-amyloid protein. The invention further relates to a pharmaceutical composition, test kit, nucleic acid molecule, expression vector, host cell, a method for producing the composition, method of diagnosis of an amyloid-associated disease or condition, method of determining the extent of amyloidogenic plaque burden in a tissue sample, method for preventing, treating or alleviating the effects of one or more amyloidosis-related diseases, methods and compositions for preventing or addressing the complications associated with amyloidosis, a group of diseases and disorders associated with amyloid plaque formation including secondary amyloidosis and age-related amyloidosis including, but not limited to, neurological disorders such as Alzheimer's Disease (AD), Lewy body dementia, Down's syndrome, hereditary cerebral hemorrhage with amyloidosis (Dutch type); the Guam Parkinson-Dementia complex; as well as other diseases which are based on or associated with amyloid-like proteins such as progressive supranuclear palsy, multiple sclerosis; Creutzfeld Jacob disease, Parkinson's disease, HIV-related dementia, ALS (amyotropic lateral sclerosis), Adult Onset Diabetes; senile cardiac amyloidosis; endocrine tumors, and others, including macular degeneration.
UAA200900880A 2006-07-14 2007-07-13 HUMANIZED ANTIBODY TO b-AMYLOID PROTEIN UA100672C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06014730 2006-07-14
PCT/US2007/073504 WO2008011348A2 (en) 2006-07-14 2007-07-13 Humanized antibody against amyloid beta

Publications (1)

Publication Number Publication Date
UA100672C2 true UA100672C2 (en) 2013-01-25

Family

ID=41040485

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200900880A UA100672C2 (en) 2006-07-14 2007-07-13 HUMANIZED ANTIBODY TO b-AMYLOID PROTEIN

Country Status (3)

Country Link
AR (2) AR107315A2 (en)
UA (1) UA100672C2 (en)
ZA (1) ZA200900313B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9573994B2 (en) * 2014-07-10 2017-02-21 Bioarctic Neuroscience Ab Aβ protofibril binding antibodies

Also Published As

Publication number Publication date
AR107315A2 (en) 2018-04-18
AR112975A2 (en) 2020-01-15
ZA200900313B (en) 2010-06-30

Similar Documents

Publication Publication Date Title
JP6795649B2 (en) Immunological targeting method for pathological tau protein
WO2007068412A3 (en) A beta 1-42 specific monoclonal antibodies with therapeutic properties
KR101783058B1 (en) Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
Schmidt et al. Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease
US20230295283A1 (en) N-terminal truncated protofibrils/ oligomers for use in therapeutic and diagnostic methods for alzheimer's
WO2008060364A3 (en) Humani zed antibody against amyloid beta
MX2009013503A (en) Monoclonal anti beta amyloid antibody.
MX2009003468A (en) Antibodies.
NZ738595A (en) Antibodies specific for hyperphosphorylated tau and methods of use thereof
BRPI0709050A2 (en) antibody or fragment thereof, composition, methods for preventing or treating, and for diagnosing disorders, methods for detecting ab protofibrils in vitro, and use of the antibody
EP2356144B1 (en) Composition for producing antibodies binding to anti-amyloid beta peptide with d-peptides
EP1978035A1 (en) Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases
UA102368C2 (en) SPECIFIC IN RELATION b-AMYLOID 1-42 MONOKLONAL'NI ANTIBODIES WHICH ARE THERAPEUTIC CHARACTERISTICS
UA100672C2 (en) HUMANIZED ANTIBODY TO b-AMYLOID PROTEIN
JP2022528459A (en) Fusion constructs and their use
EP3126839B1 (en) Agents useful in diagnostic and therapy of beta-amyloid aggregation related disorders and screening methods
WO2001090187A3 (en) G-protein coupled olfactory receptors
WO2005003288A3 (en) Diagnostic methods , prognostic methods and pharmaceutical compositions for neurodegenerative diseases like alzheimer’s disease by modulating and investigating genes rgs4 and itpkb, their gene products or fragments and derivatives thereof
ES2356159T3 (en) SELECTED ANTIBODIES OF IMPROVED PROTOFIBRILLES AND THEIR USE.